Bouygues shares have been fluctuating horizontalally for several weeks. As the share price approaches the lower bounds, a buying opportunity could arise. Investors should buy the stock at current prices near € 31 in order to target the € 35.5.
The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
The company has a good ESG score relative to its sector, according to Refinitiv.
The company's attractive earnings multiples are brought to light by a P/E ratio at 10.97 for the current year.
The company shows low valuation levels, with an enterprise value at 0.39 times its sales.
The company's share price in relation to its net book value makes it look relatively cheap.
The company is one of the best yield companies with high dividend expectations.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The opinion of analysts covering the stock has improved over the past four months.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
Historically, the company has been releasing figures that are above expectations.
With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.